Loading current evidence…
Public records only. Your private brief and follow-up notes are not included.
Ask what this evidence establishes, what remains open, or what to check next.
Notice from the National Medical Products Administration on Cracking Down on Illegal Activities Involving the Manufacture and Sale of Counterfeit and Substandard Medicines and Medical Devices, and Effectively Ensuring the Safety of Medicines and Medical Devices for the Prevention and Control of the Novel Coronavirus Pneumonia Outbreak
国药监法〔2020〕3号 · 药监局 · dated 2020-02-04, 2471 days ago
Found by citation: a local document that names this directive by its number or 《title》. One that restates it without naming it is not counted here. A citation shows the document names the directive, not that it carries all of it out, and a gap is not a finding of non-compliance.
The first held document from each province that cites the directive: from the provincial government, its departments, or a city or county. In the 6 provinces marked "full" we hold the provincial government's own document list (省政府 and its General Office), so a gap there is more telling; but a response can come from a department, be published outside that list, or name the directive without its number or title. Elsewhere "none found" may only mean we have not collected the document.
No held local document cites this directive yet.